For biologic-experienced patients hospitalized with acute severe ulcerative colitis, off-label, high-intensity doses of tofacitinib (Xeljanz) given with intravenous corticosteroids may have reduced ...

Individuals with IBD undergoing colectomy may benefit from surveillance for kidney function. Patients with inflammatory bowel disease (IBD) undergoing colectomy have higher rates of acute kidney ...

Please provide your email address to receive an email when new articles are posted on . Accelerated infliximab induction reduced odds of a colectomy at 2 years in acute ulcerative colitis. Therapeutic ...

The increased use of advanced medical therapies has not extended the time to colectomy or reduced colorectal cancer (CRC) rates in patients with ulcerative colitis; however, an increased rate of ...

For example, if a patient has ulcerative colitis or Crohn's disease that is not well controlled with medication, or if a colonoscopy shows precancerous lesions, a doctor may recommend a total or ...

The risk for colectomy declined over the past two decades among Finnish patients with newly diagnosed ulcerative colitis (UC), particularly between 2013 and 2020, when several advanced treatment ...

(A) Severe ulcerative colitis with ulceration and spontaneous bleeding (the Mayo Endoscopy Score =3); (B) Colitis-associated high-grade dysplasia in a flat rectal lesion (green arrows); (C) Normal ...

Response to the combination of cetuximab, bevacizumab and irinotecan (cetux/bev/iri) in patients (pts) previously treated with 3rd-line panitumumab, following disease progression on oxaliplatin, ...